"Zearalenone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
(S-(E))-3,4,5,6,8,10-Hexahydro-14,16-dihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1,7(8H)-dione. One of a group of compounds known under the general designation of resorcylic acid lactones. Cis, trans, dextro and levo forms have been isolated from the fungus Gibberella zeae (formerly Fusarium graminearum). They have estrogenic activity, cause toxicity in livestock as feed contaminant, and have been used as anabolic or estrogen substitutes.
| Descriptor ID |
D015025
|
| MeSH Number(s) |
D02.455.426.559.389.657.852.900 D02.540.950 D23.946.587.989
|
| Concept/Terms |
Zearalenone- Zearalenone
- F2 Toxin
- Toxin, F2
- F-2 Toxin
- F 2 Toxin
- Toxin, F-2
|
Below are MeSH descriptors whose meaning is more general than "Zearalenone".
Below are MeSH descriptors whose meaning is more specific than "Zearalenone".
This graph shows the total number of publications written about "Zearalenone" by people in this website by year, and whether "Zearalenone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2013 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Zearalenone" by people in Profiles.
-
A Unified Synthetic Approach to Optically Pure Curvularin-Type Metabolites. J Org Chem. 2019 06 07; 84(11):7227-7237.
-
TAK1 inhibitor 5Z-7-oxozeaenol sensitizes cervical cancer to doxorubicin-induced apoptosis. Oncotarget. 2017 May 16; 8(20):33666-33675.
-
TAK1 inhibitor 5Z-7-oxozeaenol sensitizes neuroblastoma to chemotherapy. Apoptosis. 2013 Oct; 18(10):1224-34.
-
Natural dietary ingredients (oats and alfalfa) induce covalent DNA modifications (I-compounds) in rat liver and kidney. Nutr Cancer. 1992; 17(3):205-16.